LIBETTA, CARMELO
 Distribuzione geografica
Continente #
NA - Nord America 3.709
EU - Europa 3.097
AS - Asia 1.718
AF - Africa 8
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 4
SA - Sud America 2
Totale 8.544
Nazione #
US - Stati Uniti d'America 3.697
CN - Cina 1.699
IE - Irlanda 1.109
UA - Ucraina 597
FI - Finlandia 351
DE - Germania 301
SE - Svezia 271
IT - Italia 204
GB - Regno Unito 126
BE - Belgio 62
FR - Francia 54
CA - Canada 12
IN - India 11
MU - Mauritius 8
NL - Olanda 8
RU - Federazione Russa 5
AU - Australia 4
EU - Europa 4
KR - Corea 3
CZ - Repubblica Ceca 2
LV - Lettonia 2
MY - Malesia 2
NZ - Nuova Zelanda 2
PL - Polonia 2
TR - Turchia 2
AT - Austria 1
BR - Brasile 1
CL - Cile 1
ES - Italia 1
GR - Grecia 1
IR - Iran 1
Totale 8.544
Città #
Dublin 1.107
Chandler 916
Jacksonville 735
Nanjing 553
Ashburn 257
Nanchang 187
Princeton 177
Lawrence 173
Medford 168
Changsha 164
Wilmington 159
Hebei 158
Shenyang 157
Jiaxing 114
Beijing 105
Boardman 86
Hangzhou 79
Ann Arbor 74
Tianjin 73
Helsinki 63
Brussels 62
Woodbridge 57
New York 44
Milan 42
Verona 39
Norwalk 31
Torino 25
Pavia 20
Collegno 17
Seattle 15
Fairfield 14
Kunming 14
Shanghai 13
Houston 10
Los Angeles 10
Jinan 9
Washington 9
Auburn Hills 8
Guangzhou 8
Des Moines 7
Lucera 7
Ningbo 7
Taizhou 7
Zhengzhou 7
Falls Church 6
Toronto 6
Redwood City 5
Brescia 4
Cernusco sul Naviglio 4
Dearborn 4
Hanover 4
Orange 4
Ottawa 4
Falkenstein 3
Fuzhou 3
Melbourne 3
Pune 3
Rome 3
Bangalore 2
Berlin 2
Borås 2
Brno 2
Changchun 2
Erlangen 2
Kemerovo 2
Lanzhou 2
Molfetta 2
Novokuznetsk 2
Pedrengo 2
Portsmouth 2
Rockville 2
Trieste 2
Athens 1
Auckland 1
Buffalo 1
Canberra 1
Cedar Knolls 1
Chennai 1
Chicago 1
Florence 1
Gropello Cairoli 1
Jaipur 1
Las Vegas 1
Magnago 1
Marina di Gioiosa Ionica 1
Markham 1
Monza 1
Palmerston North 1
San Francisco 1
Sasso Marconi 1
Tappahannock 1
Tomsk 1
Tortosa 1
Warsaw 1
West Columbia 1
Wuhan 1
Totale 6.095
Nome #
Costimulatory Pathways in Kidney Transplantation: Pathogenetic Role, Clinical Significance and New Therapeutic Opportunities. 93
Multiple electrolyte disorders in a neurosurgical patient: solving the rebus. 90
Antineutrophil Cytoplasmic Antibody-Associated Renal Vasculitis Treated With Autologous Mesenchymal Stromal Cells: Evaluation of the Contribution of Immune-Mediated Mechanisms. 82
Macrophage stimulating protein (MSP) determina proliferazione e migrazione delle cellule mesangiali 82
Mesenchymal stromal cells reset the scatter factor system and cytokine network in experimental kidney transplantation. 82
· Association between elevated homocysteine levels and interleukin-18 in long-term hemodialysed patients 76
C-reactive protein and coronary heart disease in hemodialyzed patients. 75
Biocompatibilita' del trattamento emodialitico: confronto tra dialisi extracorporea e dialisi peritoneale. 74
Autoimmune response to heat shock protein 60 in haemodialysis patients 74
Hemodialysis stimulates the injurins-hepatocyte growth factor release 73
Activation of PPARgamma enhances in vitro the immunosuppressive effect of cyclosporine on T lymphocytes. 72
Acute effects of cyclosporin on renal hemodinamics and urinary protein excretion in patients with the nephrotic syndrome 72
Urinary monocyte chemotactic peptide (U/MCP-1) and RANTES (U/RANTES) excretion in human lupus nephritis (SLE/N) 70
Hemodialysis related interleukin-2 receptor release by peripheral blood mononuclear cells 69
High-levels of Serum Amyloid-a (saa) and Increased Peripheral-blood Mononuclear-cells (pbmc) Production of Interleukin-6 (il-6) and Beta-2-microglobulin (b-2-m) In Hemodialysis (hd) and Peritoneal-dialysis (capd) Patients 69
Hyperhomocysteinemia in renal transplant recipients is influenced by the immunosuppressive regimen 69
Alterazione del bilancio Th1/Th2 nei pazienti in trattamento emodialitico: effetto di differenti membrane. 69
Activation of PPARgamma enhances in vitro the immunosuppressive effect of cyclosporine on T lymphocytes. 68
Autoimmune response to heat shock protein 60 in haemodialysis patients 67
Intermittent hemodiafiltration in refractory congestive heart failure: bnp and balance of inflammatory cytokines 67
Hepatocyte growth factor protects the liver against hepatitis C virus in patients on regular hemodialysis. 67
Urinary interleukin-18 (IL-18) and monocyte chemotactic peptide-1 (MCP-1) excretion in IGA Nephropathy (IgAN) 65
) Homocysteine plasma levels correlate with intimal carotid artery tickness in haemodialysis patients. 65
Circulating serum lectins of patients with IgA Nephropathy stimulate IL-6 release from mesangial cells. 65
Hemodialysis alters tyrosine phosphorylation in band 3 protein of erythrocytes 65
Standard Hemodiafiltration Improves diuretic responsiveness in advanced congestive heart failure 64
The effect of sirolimus- or cyclosporine-based immunosuppression effects on T-cell subsets in vivo 64
Cytokines are "injurin" and cause hepatocyte growth factor release during dialysis. 64
B-type natriuretic peptide dialysis clearance and renal function in patients with decompensated heart failure. 64
Acute kidney injury: effect of hemodialysis membrane on Hgf and recovery of renal function. 63
Polarization of T-Helper lymphocytes toward Th2 phenotype in uremic patients 63
Produzione dei recettori dell'Interleuchina 2 dalle cellule linfocitarie dei pazienti uremici cronici. 63
Hepatocyte growth factor protects liver against HCV in patients on regular hemodialysis. 63
ANTIBODY CASES 63
Acute effects of low-dose cyclosporine on renal function and interleukin-2 in humans. 63
An open prospective randomized trial to reduce the pain of blood glucose testing: ear versus thumb 63
Role of interleukin18 (IL-18) and interleukin 12 (IL-12) in human lupus nephritis (SLE-N) 62
Severe symptomatic hyponatremia during sibutramine therapy: a case report. 62
Bicarbonate and Calcium Kinetics In Postdilutional Hemodiafiltration 62
Dopamine Counteracts the Acute Renal Effects of Cyclosporine In Normal Subjects 62
Homocysteine lowering therapy and erythropoietin resistance in maintenance dialysis patients 62
Alterazione del bilancio Th1/Th2 nei pazienti in trattamento emodialitico: effetto di differenti membrane 62
Standard hemodiafiltration improves diuretic responsiveness in advanced congestive heart failure 61
Early versus late initiation of dialysis 60
Hemodialysis Related Induction of Interleukin-6 Production By Peripheral-blood Mononuclear-cells 60
Inosine monophosphate dehydrogenase activity after mycophenolate mofetil in renal transplant patients receiving different immunosupressive combined therapy and stable after at least three months' administration. 60
Interferong and Interleukin5 production by T helper cells in renal transplant recipients treated with sirolimus-based immunosuppression 59
Inverse association between homocysteine and vascular endothelial growth factor receptor 2 serum levels in hemodialyzed and kidney transplanted patients 59
Acute Effects of Low-dose Cyclosporine On Renal-function In Normal Subjects 59
Activity of Th1/Th2 lymphocytes in primary and HCV-related mesangiocapillary glomerulonephritis. 59
Plasma fibrinogen and dialysis 58
Hepatic growth factor release during b interferon treatment of patients with HCV chronic hepatitis genotipe 1b. 58
Interleukin-6 production of uraemic haemodialysed patients: effects of different membranes. 58
PBMC microRNA-155 is up-regulated in chronic hemodialysis patients. 58
Changes is Th1/Th2 balance in hemodialysis patients: effect of different membranes 58
Effects of two-month treatment with low-oral doses of cyclosporin on renal function. 58
Interleukin-6 Production Induced In Peripheral-blood Mononuclear-cells By A Serum Factor From Iga Nephropathy Patients Is Inhibited In-vitro By Specific Sugars 58
B-type natriuretic peptide dialysis clearance and renal function in patients with decompensated heart failure 57
Prevalence of hyperhomocysteinemia in male hemodialysis patients. 57
Effetti della ciclosporina su colture di fibroblasti e cellule epiteliali tubulari renali. 57
Stimulation of Hepatocyte Growth Factor in human acute renal failure 57
Dialysis treatment and regulatory T cells. 57
Standard hemodiafiltration improves diuretic responsiveness in advanced congestive heart failure. 57
Oxidative stress and inflammation: Implications in uremia and hemodialysis 57
B-type natriuretic peptide dialysis clearance and renal function in patients with decompensated heart failure 57
Inflammatory effects of peritoneal dialysis: evidence of systemic monocyte activation. 56
Regulatory T cells in kidney transplant recipients. 56
Nifedipine But Not Captopril Minimizes the Negative Renal Effects of the High Osmolality Contrast-media In Patients With Reduced Renal-function 56
Hepatocyte growth factor protects the liver against hepatitis C virus in patients on regular hemodialysis 56
Acute Effects of Ciclosporin On Renal Hemodynamics and Urinary Protein Excretion In Patients With the Nephrotic Syndrome 56
Folic acid for stroke prevention 56
Vitamin E-loaded dialyzer resets PBMC-operated cytokine network in dialysis patients 56
Serum levels of interleukin12, interleukin 18 and interferon gamma in ischemic acute renal failure (ARF) 56
Effetti delle differenti soluzioni di reinfusione sulla cinetica del calcio in corso di Paired Filtration Dialysis 55
Loop diuretics and renal vasodilators in acute renal failure. 55
Folic acid for stroke prevention 55
Acute Renal and Immunological Effects of Low-dose Cyclosporine In Humans 55
Hemodialysis stimulates hepatocyte growth factor release. 55
Plasma levels and blood mononuclear cell release of IL-18 in patients on hemodialysis 55
Acute effects of low dose cyclosporine on renal function in normal subjects. 55
In-vivo Effects of Intravenous 1,25-dihydroxyvitamin-d3 (1,25-vit-d3) On Interleukin-2 (il-2) Production In Hemodialysis (hd) Patients 55
Produzione linfomonocitaria di interleuchina 12 in pazienti uremici cronici. 54
Renal Functional Reserve In Renal-transplant Patients On Cyclosporine Therapy 54
Interleukin 6 production of uremic hemodialysed patients: effects of different membranes. 53
Homocysteine plasma levels correlate with intimal carotid artery thickness in haemodialysis patients 53
Hemodialysis prevents liver disease caused by hepatitis C virus: Role of hepatocyte growth factor 53
IL-6 production induced in peripheral blood mononuclear cells by a serum factor from IgA nephropathy patients is inhibited in vitro by specific sugars. 52
Renal Hemodynamic-effects of Short-term Therapy With Low-doses of Cyclosporine A In Humans With Intact Kidneys 52
Incidence of SAR and CAN in renal transplant patients treated with different immunosuppressive regimens 52
Influence of methylprednisolone on plasma homocysteine levels in cadaveric renal transplant recipients 52
Polarization of T-helper lymphocytes toward the Th2 phenotype in uremic patients 52
Loop Diuretics and Renal Vasodilators In Acute-renal-failure 51
Hemodialysis related interleukin-2 receptor release by peripheral blood mononuclear cells. 50
Effect of vitamin-E modified multilayer hemodialyser on dysregulation of IL-12 and IL-18 release by peripheral blood mononuclear cells (PBMC) 50
RBP4: a culprit for insulin resistance in end stage renal disease that can be cleared by hemodiafiltration 50
Hemodialysis stimulates hepatocyte growth factor release 49
Correlazione tra iperomocisteinemia e livelli sierici di IL-18 in pazienti in trattamento emodialitico cronico 48
Folic acid for stroke prevention. 48
High-dose folic acid supplements and responsiveness to rHu-EPO in HD patients 48
L'emodialisi induce una variazione conformazionale della beta-2 microglobulina (B-2M) espressa sulla superficie dei leucociti circolanti 48
Totale 6.085
Categoria #
all - tutte 26.965
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.965


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019156 0 0 0 0 0 0 0 0 131 4 0 21
2019/20202.166 622 887 7 109 0 125 11 113 43 173 63 13
2020/20211.134 129 97 50 111 4 155 7 170 51 171 148 41
2021/2022743 11 3 6 10 48 20 13 31 44 18 122 417
2022/20232.768 274 162 39 246 251 277 5 149 1.267 12 55 31
2023/2024698 122 109 23 102 84 199 15 39 5 0 0 0
Totale 8.683